UPAR is a GPI anchored protein, which is found in both lipid rafts and in more fluid regions of the plasma membrane. We have studied the role of the ligand uPA on uPAR localization and on the composition of the lipid membrane microdomains. We have analyzed the glycosphingolipid environment of uPAR in detergent resistant membrane (DRM) fractions prepared by cell lysis with 1% Triton X-100 and fractionated by sucrose gradient centrifugation obtained from HEK293-uPAR cells. The uPAR specific lipid membrane microdomain has been separated from the total DRM fraction by immunoprecipitation with an anti-uPAR specific antibody under conditions that preserve membrane integrity. We have also tested uPA-induced ERK phosphorylation in the presence of methyl-β-cyclodextrin, which is known to disrupt lipid rafts by sequestering cholesterol from such domains. Our results show that uPAR is partially associated with DRM and this association is increased by ligands, is independent of the catalytic activity of uPA, and is required for intracellular signalling. In the absence of ligands, uPAR experiences a lipid environment very similar to that of total DRM, enriched in sphingomyelin and glycosphingolipids. However, after treatment of cells with uPA or ATF the lipid environment is strongly impoverished of neutral glycosphingolipids.
Introduction
Extracellular proteolysis is a key element in diverse cellular processes including cell adhesion, proliferation and migration. These processes are involved in tissue remodelling, inflammation and tumour progression. The urokinase receptor (uPAR/ CD87), by binding its specific ligand uPA at the cell surface allows the conversion of plasminogen into plasmin with the consequent degradation of the extracellular matrix. UPAR is a heterogeneously glycosylated protein of 45-55 kDa, inserted into the external leaflet of the plasma membrane through a glycosylphosphatidylinositol (GPI) anchor [4] . UPAR is able to activate different signal transduction pathways inside the cell, events that are dependent on uPA binding, but in some cases independent of the catalytic activity of uPA [5] . Since uPAR lacks a transmembrane domain, the signalling events triggered after uPA binding might be explained considering that uPAR can interact with other proteins either directly or as part of a multiprotein complex. Among the proteins that associate with uPAR, integrins, FPRL1 (a homologue of the fMLP receptor, FPR), LRP-1 (low-density lipoprotein-receptor-related protein), EGF-R (Epidermal Growth Factor Receptor), caveolin-1, and vitronectin can be mentioned. Through these associations uPAR can modify the state of the cell, controlling cell adhesion, migration and proliferation [5] .
As other GPI-anchored proteins, uPAR is enriched in lipid rafts [6, 7] . Lipid rafts or lipid membrane microdomains have been biochemically characterized by their resistance to solubilization with non ionic detergents at low temperatures [8, 9] . These conditions lead to the isolation of detergentresistant membranes (DRM), which have been extensively used in order to study lipid raft composition and function. DRMs are highly enriched in cholesterol and sphingolipids, such as sphingomyelin, ceramide and glycosphingolipids [8, 10, 11] . Because of their composition, lipid rafts are more ordered and less fluid than other regions of the plasma membrane [8, 12] . These lipid membrane microdomains are also typically enriched, temporarily or permanently, in some proteins. These include integral membrane proteins, such as caveolins, flotillins and VIP36, GPI-anchored proteins like PLAP and Thy-1, some transmembrane proteins such as growth factor receptor tyrosine kinases, and signalling effectors such as G proteins and Srcfamily tyrosine kinases [13, 14] . Lipid rafts have been involved in signal transduction events, vesicular trafficking, protein sorting and entrance of intracellular pathogens [13] [14] [15] [16] .
No information is available concerning the biochemical nature of uPAR environment within lipid rafts. The aim of this study was to identify and characterize the lipid rafts in which uPAR is located at steady-state conditions, i.e. in the absence of its extracellular ligand uPA. We also wanted to investigate whether the cell membrane microenvironment in which uPAR is located is modified after receptor activation by its ligand uPA (or ATF, the amino terminal, proteolytically inactive fragment of uPA). In this paper we analyze some aspects of the lipid composition of membrane fractions immunoprecipitated with a specific anti uPAR antibody, from a detergent-resistant, cholesterol-and sphingolipid-enriched membrane fraction prepared from epithelial cells. We demonstrate that uPAR is partially associated to the detergent-resistant membranes (DRM) obtained from HEK293-uPAR cells, and that after uPA binding there is a 3-fold increase in uPAR association to the DRM. We also show that uPA or ATF binding enrich the cell membrane microenvironment in which uPAR is located of sphingomyelin and gangliosides, while depleting it of neutral glycosphingolipids. The functional relevance of the presence of uPAR in lipid microdomains is shown by the complete inhibition of uPA intracellular signalling in methyl-β-cyclodextrin (CD)-treated cells in which lipid rafts are disrupted. We conclude that uPAR is located in specific subdomains within lipid rafts, the composition of which as well as uPAR distribution in the plasma cell membrane is regulated by its ligand uPA.
Materials and methods

Materials
Cell culture media and supplements were purchase from Gibco-BRL (Carlsbad, CA, USA) and plastic ware was from Costar (Cambridge, MA, USA). Triton X-100, methyl-β-cyclodextrin and general laboratory chemicals were from Sigma-Aldrich (St. Louis, MO, USA). Secondary HRP-conjugated antibodies and Redivue L-[ 35 S]methionine were from Amersham Pharmacia Biotech (Buckinghamshire, UK). PVDF membranes were from Millipore (MA, USA). Chemoluminescent substrate was from Pierce (IL, USA). Clinical grade uPA was obtained from Crinos (Italy). The R4 anti-uPAR antibodies were kindly provided by Dr. Gunilla Høyer-Hansen (Finsen Laboratory, Copenhagen, Denmark). The polyclonal anti-uPAR antibodies as well as ATF (the Amino Terminal Fragment of uPA) were produced and tested in our laboratory [6] . The monoclonal antibodies to Transferrin Receptor were purchased from Zymed Laboratories (S. San Francisco, CA, USA). The rabbit polyclonal antibodies to Caveolin-1 were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). The rabbit polyclonal antibodies to Phospho-p44/42 MAP Kinase were purchased from Cell Signalling Technology, Inc. (Danvers, MA, USA), while the rabbit polyclonal antibodies to total ERK were from Santa Cruz Biotechnology, Inc. Protein G-Sepharose beads were from Amersham Pharmacia Biotech (Buckinghamshire, UK). Protein G-coupled magnetic beads (Dynabeads) were from Dynal ASA (Smestad, Oslo, Norway). Sphingosine was prepared from cerebroside [40] . [1] [2] [3] H]sphingosine was prepared by specific chemical oxidation of the primary hydroxyl group of sphingosine followed by reduction with sodium boro[ 3 H]hydride [41] (radiochemical purity over 98%; specific radioactivity 2 Ci/ mmol). Tritiated lipids were extracted from [1] [2] [3] H]sphingosine-fed cells, purified, characterized and used as chromatographic standards. Sphingolipids and glycerolipids to be used as standards were extracted from rat brain, purified and characterized [42] .
Cell culture
HEK293 cells stably transfected with human uPAR were cultured in Dulbecco's Modified Eagle Medium supplemented with penicillin (100 U/ml), streptomycin (100 U/ml), glutamine (5 mM), G418 (0.8 mg/ml) and 10% fetal bovine serum at 37°C in 5% CO 2 .
Metabolic radiolabeling
HEK 293-uPAR cells were incubated with 3.7 × 10
H]sphingosine (16 ml/162 cm 2 flask) in culture medium for 2 h. After the pulse, medium was replaced with fresh culture medium without radioactive sphingosine and cells were chased for 48 h. Under these conditions, all sphingolipids (including ceramide, sphingomyelin, neutral glycolipids and gangliosides) and phosphatidylethanolamine (obtained by recycling of radioactive ethanolamine formed in the catabolism of [1- 3 H] sphingosine) are metabolically radiolabelled [43] .
In order to radiolabel proteins, cells were incubated in methionine-free medium for 2 h and subsequently incubated in the presence of 17 μCi/ml L- [ 35 S] methionine for 20 h.
Purification of detergent-resistant membranes (DRM)
HEK 293-uPAR cells were plated at 70% confluence and lipids and proteins were metabolically radiolabelled with [1] [2] [3] H]sphingosine or L-[ 35 S]methionine, respectively, as described above. After metabolic radiolabeling, cells were washed twice with cold PBS, collected by scraping and centrifuged 5 min at 1200 rpm. Cells were lysed for 30 min on ice in ice-cold buffer A (150 mM NaCl, 2 mM EDTA, 50 mM Tris-HCl, pH 7.5) containing 1% TX-100 and a cocktail of proteinase inhibitors (Complete, Roche, Basel, Switzerland). Cell lysates were centrifuged at 4°C for 5 min at 1200×g. One ml of this postnuclear supernatant was brought to 40% sucrose using 80% sucrose in buffer A plus detergent, placed at the bottom of a ultracentrifuge tube (Beckman Instruments Inc, Fullerton, CA, USA ) and overlaid with 4 ml of 30% sucrose and 2 ml of 5% sucrose in buffer A plus detergent, and filled up with 4 ml of buffer alone. Samples were centrifuged at 4°C for 17 h at 39,000 rpm (Beckman ultracentrifuge rotor SW41Ti). After centrifugation, 1 ml fractions were collected from the top to the bottom of the gradient using a pipette. Eight fractions were collected. Fractions 2 and 3 were determined to correspond to DRM and fractions 7 and 8 to detergent soluble material (DS).
The sucrose density fractions obtained were analyzed to determine the protein distribution (by running the same fraction volume in SDS-PAGE followed by immunoblotting) as well as the content and distribution of radiolabelled lipids as described below.
Analysis of protein patterns
Cell lysates and sucrose gradient fractions obtained after labelling cells with [ 35 S]methionine were analyzed to determine protein content and pattern. Similar volumes of each sucrose density fraction were subjected to SDS-PAGE on 10% acrylamide gels followed by immunoblotting.
ERK phosphorylation
To perform time course analysis, HEK 293-uPAR cells (80% confluence) were serum-starved for 16 h and then incubated with 10 nM uPA for the indicated times at 37°C. Then cells were washed with cold PBS and lysed with 1× Laemmli sample buffer (100 μl per well of 12-wells plate). After scraping, the extracts were forced back and forward through a narrow gauge needle, microcentrifuged, and incubated for 5 min at 95°C. The samples were then subjected to SDS-PAGE on 10% acrylamide gels followed by immunoblotting.
For the disruption of lipid rafts, cells were pretreated for 30 min at 37°C with 10 mM methyl-β-cyclodextrin [6] . Subsequently, cells were treated for 5 min at 37°C with either medium alone, uPA 10 nM, or 10% bovine fetal serum, in the absence or presence of 10 mM methyl-β-cyclodextrin. Then cells were treated as mentioned above.
Immunoprecipitation experiments
To analyse specific lipid composition, pools of 600 μl from fractions 2+3 (DRM) and 7 + 8 (DS) obtained from the [1] [2] [3] H]sphingosine labelled cell lysates were precleared with Dynabeads-protein G for 2 h and then subjected to immunoprecipitation with a monoclonal anti uPAR antibody (R4) that had been precoupled to Dynabeads-protein G, overnight at 4°C. Parallel experiments were made with non-reactive mouse IgG as negative control. After washing 3 times with lysis buffer, lipids were extracted from the immunoprecipitates with chloroform/ methanol 2:1 (v/v) and analyzed as described below. Proteins were eluted from the beads with sample buffer under denaturating conditions, and subjected to SDS-PAGE and immunoblotting for uPAR detection.
To quantitate uPAR in the various fractions, pools of 600 μl from fractions 2 + 3 (DRM) and 7 + 8 (DS) obtained from the [ 35 S]-methionine labelled cell lysates were precleared with Sepharose-protein G for 2 h and then subjected to immunoprecipitation with a monoclonal anti uPAR antibody (R4) that had been precoupled to Sepharose-protein G, overnight at 4°C. Parallel experiments were made with nonreactive mouse IgG as negative control. After washing 3 times with lysis buffer, the amount of radioactivity present in the immunoprecipitate was determined. Then, the samples were subjected to SDS-PAGE and autoradiography.
Analysis of radioactive lipids
The cell lysate, post-nuclear supernatant and sucrose gradient fractions obtained after [1] [2] [3] H]sphingosine cell metabolic radiolabeling were analyzed to determine the content of radiolabelled lipids [12] . Samples were dialyzed for 3 days against distilled and decarbonated water. Then, samples were lyophilized, and lipids were extracted twice with 0.5 ml chloroform/methanol 2:1 (v/v) [26] . Aliquots of the lipid extracts were analyzed by HPTLC as described below, followed by radioactivity imaging for quantification. Identity of lipids separated by HPTLC was assessed by co-migration with purified molecular standards.
Thin layer chromatography
Tritiated lipids were separated by one-dimensional HPTLC carried out with the solvent systems chloroform/methanol/0.2% aqueous CaCl 2 55:45:10 v/v/v, followed by radioactivity imaging for quantification of radioactivity. In some cases, lipids were also separated by two-dimensional HPTLC, using chloroform/ methanol/water, 110:40:6 (v/v/v) as the solvent system for the first run, and chloroform/methanol/0.2% aqueous CaCl 2 , 55:45:10 (v/v/v) for the second run. Cholesterol in the lipid extracts was separated by one-dimensional HPTLC using the solvent system hexane/ethyl acetate, 3:2 (v/v). Cholesterol was quantified after separation on HPTLC by visualization with 15% concentrated sulphuric acid in 1-butanol.
Other analytical methods
The protein content was determined according to Lowry [44] , or with the micro BCA assays (Pierce Chemical Co.), using bovine serum albumin in the presence of sucrose as the reference standard.
The radioactivity associated with whole cells, cell fractions, immunoprecipitation samples, lipids and delipidized pellets was determined by liquid scintillation counting. Digital autoradiography of the HPTLC plates was performed with a BetaImager 2000 instrument (Biospace, Paris) using an acquisition time of about 24 h. The radioactivity associated with individual lipids was determined with the specific β-Vision software provided by Biospace.
Results
UPAR is enriched in detergent-resistant membranes obtained from HEK 293-uPAR cells
It has been previously reported that uPAR can be isolated from cell membranes in association with Triton X-100-resistant lowdensity membranes [6, 7] . As a first approach to identify and characterize the plasma membrane domains in which uPAR is located, we used HEK 293-uPAR cells that do not produce uPA, performed sucrose density gradients on the Triton X-100 (TX-100) extract and analyzed uPAR association with DRM, i.e. fractions 2-3 of the gradient, and DS (detergent-soluble material, i.e. fractions 7-8).
We first compared the distribution of total proteins and uPAR in the different fractions of sucrose density gradients. HEK 293 cells, stably transfected with human uPAR (HEK293-uPAR, [6] ) were incubated in methionine-free medium for 2 h and subsequently supplemented with 17 μCi/ml L-[
35 S]methionine for 20 h. After metabolic radiolabeling, cells were lysed in 1% TX-100 and then the lysates were subjected to ultracentrifugation on sucrose gradients and separated into 8 fractions.
Fractions were counted for 35 S content and analyzed by SDS-PAGE and immunoblotting. Fig. 1A (Upper Panel) shows that uPAR was present in the DRM (lanes 2 and 3), which contained less than 1% of the total [ 35 S]proteins (Fig. 1B) . Caveolin-1, in fact showed a similar distribution. On the other hand, TfR partitioned exclusively in the DS membrane fractions of the gradient, which also contained the majority of uPAR (Fig. 1A , Upper Panel, lanes 6-8). Besides, the DS fractions contained more than 70% of the total cell protein radioactivity (Fig. 1B) . Immunoprecipitation of uPAR from the DRM and DS fractions isolated from L-[
35 S]-methionine labelled-cells (Fig. 1C , arrow) and counting of the precipitated radioactivity showed that uPAR was highly enriched in these fractions (close to hundred fold), while constituting only 0.03% of the total proteins ( Table 1) . The heterogeneous glycosylation pattern and the presence of both full-length and truncated forms (D2D3 forms) of uPAR, account for the double, enlarged and fuzzy band of Fig. 1C [4,5] .
UPA binding increases uPAR association to detergent-resistant membranes independently of its catalytic activity
It has been widely described that uPA binding to uPAR induces both proteolysis-dependent and independent intracellular signalling events that affect adhesion, migration, and proliferation in a variety of cells [5] . Here, we studied whether uPA plays a role in uPAR localization to lipid rafts. HEK 293-uPAR cells were incubated either with 10 nM uPA or ATF (the Amino Terminal Fragment of uPA that binds to the receptor but lacks the catalytic domain) for 5 min at 37°C, enough to saturate cell surface uPAR [5] and to induce intracellular signalling (see below). After the incubation period, cells were lysed in 1% TX-100 and treated as described above. Interestingly, after uPA binding there was a three-fold increase in uPAR content in the DRM (i.e. from about 5% to about 15%, 1A, middle panel, lanes 2 and 3) , while TfR and caveolin-1 maintained the same distribution pattern (Fig. 1A ). An increase in uPAR association to DRM is also observed after ATF binding, suggesting that this event is independent of the catalytic activity of uPA (Fig. 1A, lower panel, lanes 2 and 3) .
Disruption of lipid rafts completely prevents uPA/uPAR intracellular signalling
To investigate the relevance of uPAR localization in lipid microdomains we tested the rate of ERK phosphorylation in conditions in which we previously demonstrated that lipid rafts are disrupted, and uPAR is found exclusively in the DS membrane fractions (not shown, but see [6] ). First, we analyzed the rate of ERK phosphorylation induced by uPA at different time points. As shown in Fig. 2A , uPA induces ERK phosphorylation within 1 min. This activation is transient, since the phosphorylated ERK returns to basal levels in less than 15 min. Then, we compared the rate of ERK phosphorylation induced by uPA in untreated or 10 mM CD-treated HEK293-uPAR cells. Under the last condition uPAR is found exclusively in the DS membrane fractions (not shown and [6] ). Stimulation with serum, another inducer of ERK that does not act through uPAR, was used as control. As shown in Fig. 2B , uPA induced ERK phosphorylation in untreated cells after 5 min of incubation, whereas CD-treatment prevented ERK phosphorylation altogether. Unlike uPA, the treatment of cells with CD had no effect on the serum-induced ERK phosphorylation (Fig. 2B) . This result is also in agreement with previously reported data on the same cells in which CD treatment specifically blocked uPAR-dependent, but not integrin-dependent, adhesion on vitronectin [6] . Thus, we conclude that the presence of uPAR in lipid microdomains is relevant for its signalling function. On these premises, we have decided to analyze the lipid composition of the uPAR-containing microdomains and test whether uPA binding would induce any change in the lipid microdomains.
UPAR associates with sphingolipid and cholesterol-enriched detergent-resistant membranes
To characterize the lipid composition of uPAR membrane microdomain, sphingolipids were metabolically labelled with [1- 3 H]sphingosine. [1-3 H]sphingosine is rapidly taken up by cultured cells and is efficiently converted into complex sphingolipids. Moreover, it is in part catabolized to tritiated ethanolamine, that is recycled for the biosynthesis of phosphatidylethanolamine (PE), a glycerophospholipid that can be conveniently used as a marker of non-DRM fractions [12, 17] . After metabolic radiolabeling, cells were first incubated with 10 nM uPA or ATF for 5 min at 37°C and then lysed in 1% TX-100. The lysates were subjected to ultracentrifugation on sucrose gradients and separated into 8 fractions. The radioactive lipids were extracted, separated by HPTLC and analyzed by radioimaging. The radioactive lipid patterns of the gradient fractions and the quantitative distribution of radioactive sphingolipids and PE are not shown but are available in Suppl. Figure 1 . No statistically significant differences were observed between cells incubated with medium alone, uPA or ATF. The DRM fractions contained about 25% of cellular sphingolipids (25.3 and 24.8% for control and uPA-treated, 20.6% for ATF-treated cells), in particular sphingomyelin (the major SL present in these cells), ceramide, LacCer, GM2 and GM3, and other minor SL. PE, as S]-methionine uptake by the cells was of 21,920,000 cpm in total , which is considered as 100% of total cell proteins; of this about one quarter was used in this specific experiment. In additional experiments, the same results were obtained.
a The percent uPAR after immunoprecipitation is calculated after subtraction of the non specific (pre-clear), and indicated with "sp". b The fold enrichment of uPAR is calculated by dividing the percent of specific uPAR precipitated from DRM divided by the percent precipitated from the DS fraction.
expected, was located mainly in the DS membrane fractions of the gradient (Suppl. Figure 1) . The other major lipid component of membrane lipid domains is cholesterol. Thus, we also checked the distribution of cholesterol in the gradient. Again, about 25% of total cellular cholesterol was found in DRM independently of the presence of uPAR ligands (Suppl. Figure 1 ). These results demonstrate that binding of uPA or ATF does not lead to an overall modification of the lipid composition of the DRM.
UPA binding modifies the lipid composition of uPAR membrane microdomain independently of its catalytic activity
Since uPAR associates to lipid rafts, and this association is increased after uPA binding, we determined the sphingolipid content of the uPAR membrane microdomains at steady state and after uPA binding. For this purpose, pooled DRM fractions (fractions 2 and 3) from the sucrose density gradients shown in Fig. 1 and Suppl. Figure 1 were subjected to immunoprecipitation with the anti-uPAR monoclonal antibody R4, under conditions designed to preserve the integrity of the domains (see Methods section) [18] . We also used non-reactive IgG as a negative control. By Western blot assays we determined that the immunoprecipitates performed with R4 contained the uPAR associated to DRM (Fig. 3) . In control, uPA, and ATF-treated cells, uPAR was present in both the full length and the cleaved (D2D3) forms. However, no uPAR was found in the precipitate with non-reactive IgG. The presence of D2D3 form is in keeping with the higher sensitivity of DRM-uPAR (as opposed to DS-uPAR) to cleavage by uPA or other endogenous protease [6] .
The specific (R4 antibody) immunoprecipitate contained about 10% (from 8.8 to 11%) of the total tritium labelled sphingolipids associated to DRM, in the three conditions tested (control, uPA-or ATF-treated, Table 2 ). Less than 0.5% of the total tritium labelling was associated with the non-reactive IgG and with the protein G-coupled magnetic beads used to preclear the samples (Table 2) . No uPAR was detected with the protein G-coupled magnetic beads alone (not shown). The recovery was higher than 85% in all the samples.
It is worth mentioning that when the DS fractions obtained from the sucrose density gradients of Fig. 1 and Suppl. Figure 1 were subjected to immunoprecipitation with the antibody R4, uPAR was effectively precipitated, but the immunoprecipitates contained less than 2% of the radioactive lipids present in the DS fractions, mainly represented by PE (data not shown).
Tritiated lipids extracted from the uPAR immunoprecipitates were analyzed by two-dimensional HPTLC and compared to those from the DRM (Fig. 4) . The DRM from cells incubated with medium alone, uPA or ATF contained sphingomyelin, gangliosides GM2 and GM3, neutral glycosphingolipids GlcCer and LacCer, and ceramide (Fig. 4A, left panel) . The two-dimensional lipid patterns of the DRM in control, uPA-and ATF-treated cells were very similar. Moreover, the lipid composition of the uPAR immunoprecipitate in control cells did not significantly differ from that of the total DRM (Fig. 4A, upper panel) . However, in the uPAR immunoprecipitates from both uPA-and ATF-treated cells (Fig. 4A, middle and lower panels), we found a much lower amount of neutral glycosphingolipids, which remained in the supernatant. After quantitative determination of the radioactivity associated with each spot, we found a 60% reduction in neutral glycosphingolipids in the uPAR immunoprecipitates from both uPA-and ATF-treated cells (Fig. 4B) . In these same immunoprecipitates, we found a 1.5 fold increase in GM2 and GM3 (Fig. 4B) . These results suggest that uPA binding modifies the lipid composition of uPAR membrane microdomains, and that this modification is independent of the catalytic activity of uPA.
Discussion
UPAR is a GPI anchored protein that can promote signal transduction events inside the cell independently of the catalytic activity of uPA [5] . The intracellular signalling process may be triggered by the association of uPAR to other proteins such as vitronectin [20] , integrins [21] , FPRL1 [22] , caveolin-1 [7, 19] , EGF-R (Epidermal Growth Factor Receptor) [23] and LRP-1 (low-density lipoprotein-receptor-related protein) [24] . Since uPAR is located in different compartments at the cell surface, the microenvironment, i.e., the surrounding lipids and proteins, should be important to control uPAR function. UPAR, as many other GPIanchored proteins [15, 25] , is partially localized in lipid rafts or lipid membrane microdomains, zones of the membrane particularly enriched in cholesterol and sphingolipids, being therefore partially insoluble in TX-100, and sensitive to cholesterol Fig. 3 . Immunoprecipitation of uPAR from the DRM. DRM was prepared by sucrose gradient centrifugation from control cells (left), cells treated with 10 nM uPA (middle) or with 10 nM ATF (right) for 5 min at 37°C, and subjected to immunoprecipitation performed at 4°C using anti-uPAR antibodies (lane 1). Nonreactive IgG were used as negative control. Samples were separated by SDS-PAGE and then transferred on a PVDF membrane. uPAR was visualized by Western blotting with specific antibodies. b The percent of input radioactivity is calculated after subtraction of the amount precipitated from the non reactive IgG. depletion [6, 7] . The GPI anchor is responsible for uPAR insolubility in TX-100, since a chimeric uPAR mutant, bearing the EGFR transmembrane domain in place of its GPI anchor consensus sequence, does not partition to lipid membrane domains [6] .
Lipid and protein organization at the cell surface is considered to play a crucial role in modulating functional processes, such as those associated with uPAR, and favouring their compartmentalization. This idea is supported by our experiments with CD. Indeed, after CD treatment, lipid rafts are disrupted and the uPAdependent induction of ERK phosphorylation is completely inhibited. This is a specific effect for the uPA/uPAR system, since other signals that do not go via lipid rafts are insensitive to CD (Fig. 2) . The specific adhesion of HEK239-uPAR cells onto vitronectin was also reported to be totally dependent on lipid microdomains integrity [6] . These data confirm the expected importance of lipid rafts in uPAR intracellular signalling. However, no data were available concerning the lipid composition of uPAR environment in lipid rafts. Our results show that in HEK293-uPAR cells, uPAR is partially associated to DRM, and that the association to DRM increases after ligand binding. In the absence of ligand, uPAR is located in a lipid environment very similar to that of total DRM, enriched in sphingomyelin and glycosphingolipids. However, after treatment of cells with uPA or ATF the specific lipid environment is impoverished of neutral glycosphingolipids with relative increases of sphingomyelin and gangliosides (Fig. 4) .
Although many receptors are localized in lipid rafts, the effect of the ligand in this association is highly variable. For example, the insulin receptor is recruited to lipid rafts after insulin binding [27] , while the β 2 -adrenergic receptor moves out of lipid rafts after agonist binding [28] . However, the functional implications of such changes in receptor compartmentalization are unclear. In our system, even if uPAR is already localized in lipid microdomains, more receptor is recruited into lipid rafts in the presence of its specific ligand uPA. A similar increase of uPAR association to lipid rafts is observed after ATF binding. Since ATF binds to the receptor but lacks the catalytic activity, it is the binding of uPA to uPAR but not the associated cell surface proteolysis that is required for receptor recruitment into lipid rafts. Moreover, the microenvironment of the lipid rafts in which uPAR is located changes after ligand binding. It has been proposed that by modulating the entrance of some proteins, lipid rafts can control intracellular signalling [16] . In this sense, increasing the amount of uPAR in lipid rafts after uPA binding might trigger or enhance the uPA/uPAR-related signalling activation that control cell adhesion, migration, proliferation and differentiation. Here we showed that the presence of uPAR in lipid rafts is essential for uPA/uPAR-induced ERK phosphorylation. Previously, it has been shown that the localization of uPAR and uPA in caveolae enhances pericellular plasminogen activation [7] . Other data show that dimeric uPAR partitions preferentially to lipid rafts, where it binds to vitronectin in a way that can be blocked by cholesterol depletion [6] . While uPA binds to uPAR independently of its membrane localization and dimerization status, uPA-induced uPAR cleavage is strongly accelerated in lipid rafts [6] .
Our results support the idea that a protein can belong to distinct lipid membrane domains, since the SL microenvironment in which uPAR is located changes after uPA binding. In fact it has been reported that after certain stimuli, uPAR can segregate at the leading edge of a migrating T-cell in GM3-enriched lipid rafts rather than GM1-enriched lipid rafts localized at the uropod [29] . In addition to the specific lipid composition changes induced by the ligands, we also find by confocal fluorescence and co-immunoprecipitation experiments (not shown) that uPAR does not co-localize with caveolin-1 in the plasma membrane of HEK293-uPAR cells. In fact, colocalization between uPAR and caveolin is found only in the Golgi (Cortese et al., in preparation). This finding also eliminates any doubt that the DRM fractions that we have analyzed may contain not only plasma membrane but also Golgi and other organelles membranes.
After receptor activation by ligand binding, the uPARimmunoprecipitate was enriched in gangliosides and sphingomyelin. Gangliosides are found in the outer layer of the plasma membrane and are involved in a number of biological processes such as cell adhesion, signal transduction, tumorigenesis, differentiation and metastasis [30, 31] . As one of the gangliosides enriched in the uPAR-immunoprecipitate was GM3, it could be speculated that the GM3 enrichment after uPA binding might be relevant in the role that uPAR plays in cell processes as GM3 is involved in cell motility/invasiveness [32] and EGFR dimerization and autophosphorylation [33] [34] [35] [36] . This might be relevant since, as mentioned before, EGFR and uPAR can modulate each others activity [23, 37] . However, additional studies are required to understand the functional role of GM3 enrichment in lipid raft under cellular events regulated by the uPA/uPAR system. This result is intriguing since the generation of the second messenger ceramide from SM has been suggested to occur preferentially in lipid rafts upon certain stimuli. On a speculative basis, this local change in the SL content may modify raft functioning, triggering signalling events and allowing receptor oligomerization [38, 39] . In addition, we found that neutral glycosphingolipids were diminished in the uPAR-enriched lipid rafts. According to these results, it could be hypothesized that neutral glycosphingolipids might restrict the presence of uPAR in lipid rafts from resting cells. Again, additional studies are required in order to test this hypothesis.
Altogether, these results suggest that uPAR is located in specific subdomains within lipid rafts, with characteristic lipid composition. The localization of the receptor as well as the composition of the subdomains is regulated by ligand binding. Hypothetically, this microenvironment might modify uPAR specific responses. Neutral glycosphingolipids might restrict the presence of uPAR in lipid rafts, while SM and ceramide could induce intracellular signalling cascades, and GM2 and GM3 might facilitate the association with other receptors and signalling molecules. Our findings shed light not only in the relevance of the localization of uPAR in lipid rafts, but also show the important role that lipid rafts themselves play in the selectivity and compartmentalization of cell processes.
